Haase, D., Stevenson, K., Neuberg, D., Maciejewski, J., Nazha, A., Sekeres, M., . . . Committee, I. W. G. F. M. M. P. (2019). TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. Springer Nature.
Citación estilo ChicagoHaase, D., et al. TP53 Mutation Status Divides Myelodysplastic Syndromes with Complex Karyotypes into Distinct Prognostic Subgroups. Springer Nature, 2019.
Cita MLAHaase, D., et al. TP53 Mutation Status Divides Myelodysplastic Syndromes with Complex Karyotypes into Distinct Prognostic Subgroups. Springer Nature, 2019.
Warning: These citations may not always be 100% accurate.